FDA Approved: TIROSINT SOL — Supplemental Application (IBSA Pharma Inc.)

View source ↗

Summary

The FDA approved a supplemental application for TIROSINT SOL (levothyroxine sodium) from IBSA Pharma Inc., a thyroid hormone replacement therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Hypothyroidism
• Differentiated Thyroid Carcinoma
• Goiter
• Hypothyroidism

Drugs mentioned

• Tirosint-SOL (Levothyroxine sodium oral solution)

Snippet

SUPPL AP for TIROSINT SOL (LEVOTHYROXINE SODIUM)